How to Choose a Drug Rehab in New Hampshire: A 2026 Guide

Choosing addiction treatment is one of the most important decisions a person or family will ever make. In New Hampshire, that decision is more complicated than it used to be — not because there are fewer options, but because there are more of them, the drug supply has changed significantly, and what insurance will actually cover has shifted in ways that aren’t always clear upfront.

This guide is designed to help you ask the right questions, understand what the current landscape actually looks like, and make an informed choice — wherever you end up.

Where Things Stand in New Hampshire Right Now

Before evaluating any specific facility, it helps to understand the environment you’re navigating.

The good news is real. According to the NH Governor’s Commission on Addiction, Treatment, and Prevention, drug overdose deaths in New Hampshire fell 35% from 2023 to 2024 — the lowest death toll since 2013 and the largest single-year decline in over a decade. That progress continued into 2025. Wider access to naloxone (Narcan), the expansion of community-based treatment options, and years of investment in New Hampshire’s treatment infrastructure have all contributed.

But declining deaths don’t mean declining addiction. Recovery advocates have been consistent on this point: more people are surviving overdoses, not fewer people are using. And the drug supply has changed in ways that matter when evaluating treatment programs.

Fentanyl remains the dominant driver of overdose deaths — 135 of New Hampshire’s 282 confirmed deaths in 2024 were attributed to fentanyl alone. But cocaine’s share of overdose fatalities jumped from 11% in early 2024 to 18% by mid-2025, according to the NH Drug Monitoring Initiative. Methamphetamine use continues to rise as well. The result is that most people presenting for treatment today are dealing with multiple substances — not a single-substance pattern — and a program built primarily around opioid treatment may not be adequately equipped for what they’re actually facing.

The NH Drug Monitoring Initiative has also begun tracking medetomidine — a veterinary sedative — as an emerging adulterant in the local drug supply, following xylazine (tranq) as the previous additive of concern. These adulterants complicate withdrawal and don’t respond to naloxone the way opioids do. It’s worth asking any program you consider how they approach withdrawal management for someone whose substance history includes these kinds of unknowns.

New Hampshire also saw a significant shift in treatment capacity in 2025: The Farnum Center in Manchester — one of the state’s major publicly-funded residential programs — closed to new admissions in July 2025. For people in the greater Manchester area seeking residential care, that has meant fewer publicly-funded beds and more reliance on private facilities to meet demand.

1. Start With Accreditation and State Licensing

Accreditation is the clearest external signal that a facility meets a defined, independently verified standard of care. The two most recognized accrediting bodies in behavioral health are The Joint Commission and CARF International. Accredited programs undergo rigorous review of clinical practices, patient rights, staff qualifications, medication management, and safety protocols — and are subject to ongoing accountability, not just a one-time review.

State licensing is a separate but equally important baseline. In New Hampshire, residential treatment programs and detox facilities are licensed and overseen by the Bureau of Drug and Alcohol Services (BDAS) through NH DHHS. Operating without a valid BDAS license is a red flag that should end the conversation.

SAMHSA maintains a national treatment locator at FindTreatment.gov where you can search for licensed and accredited facilities by location. Use it as a starting point, then verify directly with the facility.

2. Ask Whether the Program Is Equipped for Today’s Drug Supply

This is something that wouldn’t have appeared in a guide written three years ago. Given how significantly the drug supply has shifted, it’s now one of the most practical questions you can ask.

Because fentanyl is frequently mixed with stimulants like cocaine and methamphetamine, and because adulterants like medetomidine are increasingly present in the supply, many people entering treatment today have a much more complicated clinical picture than a single-substance opioid user did a decade ago. Stimulant use disorder doesn’t respond to the same medications used for opioid withdrawal. And if someone’s supply has included medetomidine, standard opioid withdrawal protocols may not fully address what’s happening physiologically.

Ask directly: How does your clinical team approach someone coming in with a mixed opioid and stimulant history? How do you handle withdrawal when the substance composition is unknown? A quality program in 2026 should have a real, specific answer.

3. Understand What Level of Care Is Actually Needed

“Drug rehab” covers a wide range of treatment intensities. Placing someone in the wrong level — too low or too high — can undermine outcomes before treatment has a real chance to work.

Medical Detox

For people with physical dependence on alcohol, opioids, or benzodiazepines, medical detox is typically the necessary first step. Alcohol and benzo withdrawal in particular can be medically dangerous — even life-threatening — without proper monitoring and medication management. A supervised detox provides 24-hour clinical support, vital sign monitoring, and medication intervention throughout the withdrawal process.

Liberty offers alcohol detox, opiate detox, benzo detox, and heroin detox programs with medical oversight throughout.

Residential Treatment

Following detox, many people enter residential treatment — a structured, live-in program where patients participate in individual and group therapy, skills development, and recovery planning. Residential is appropriate when someone needs a controlled environment away from the people, places, and circumstances tied to their substance use. Program length should be driven by clinical need, not a fixed calendar.

Intensive Outpatient (IOP)

Intensive outpatient programming provides structured treatment several days a week while allowing patients to live at home or in supportive housing. It’s appropriate as a step-down from residential, or for someone whose clinical situation doesn’t require 24-hour supervision. Liberty offers an evening IOP that works around work and family schedules.

A quality program conducts a thorough clinical assessment before recommending a level of care — it doesn’t default everyone into the same program regardless of need.

4. Ask Directly About Medication-Assisted Treatment

For opioid and alcohol use disorders, medication-assisted treatment is among the most evidence-supported approaches available. Medications like buprenorphine (Suboxone) and methadone reduce cravings, ease withdrawal, and significantly lower the risk of relapse and overdose — particularly in the high-vulnerability period right after detox.

Not every New Hampshire program offers MAT. Some 12-step centered programs decline it on philosophical grounds — which is worth knowing before you commit. If MAT is clinically appropriate for the person seeking treatment, a program that won’t provide it may not be the right fit.

Ask directly: Does the program offer MAT? If not, why not, and what is your approach to opioid withdrawal and relapse prevention without it?

Liberty offers Suboxone treatment and methadone treatment for those for whom it is clinically appropriate.

5. Evaluate the Clinical Team

Credentials and availability of clinical staff matter as much as any other factor. Specific questions worth asking:

• Is a physician or nurse practitioner available around the clock — not just during business hours?
• Are therapists licensed in New Hampshire?
• What is the staff-to-patient ratio, both during the day and overnight?
• Does the program build individualized treatment plans, or does everyone follow the same schedule?
• Who is actually delivering therapy — licensed clinicians, or primarily peer support staff?

Higher staff-to-patient ratios and individualized planning consistently correlate with better outcomes. A program with a large census and thin staffing may struggle to notice when someone is struggling, adjust a plan, or provide the human connection that early recovery requires.

6. Ask What Therapy Looks Like

Evidence-based approaches — Cognitive Behavioral Therapy (CBT), Motivational Interviewing (MI), Dialectical Behavior Therapy (DBT), and trauma-informed care — have the strongest research support. Ask what specific therapy programs are offered and how they’re delivered.

A strong program includes both individual therapy — one-on-one sessions with a licensed clinician — and family therapy. Programs that offer only group sessions with little to no individual clinical contact are delivering an incomplete model of care.

7. Look at the Environment

The physical setting and size of a facility affect care quality in ways that are easy to overlook when you’re making decisions under stress.

Larger programs — those with 80 or 100+ patients at a time — can struggle to deliver individualized attention. A staff stretched across a large census is less likely to notice when someone is struggling emotionally, less able to adjust a treatment plan, and less able to build the kind of trust that supports honest clinical work.

Private rooms, clean and stable living spaces, and quality meals aren’t luxuries. They’re part of what makes a physically and emotionally demanding process manageable. If possible, take a facility tour before committing. Most reputable programs welcome this.

8. Ask About Co-Occurring Mental Health Conditions

Substance use disorders co-occur with depression, anxiety, PTSD, and other mental health conditions at high rates. Treating the addiction while ignoring the underlying mental health piece is one of the most common reasons early recovery becomes unstable.

Ask whether the program screens for co-occurring disorders and whether their clinical team has the credentials and capacity to actually treat them — not just refer out. A program that handles dual diagnosis has meaningfully different staffing requirements than one that doesn’t.

9. Understand the Plan for After Discharge

What happens after discharge matters as much as what happens during treatment. The period immediately following residential care is one of the highest-risk times in recovery.

Ask: Does the facility connect patients to outpatient programming or IOP after residential? Do they facilitate connections to local support groups, sober living, or peer recovery coaches? Is there any follow-up contact after someone leaves?

New Hampshire’s Doorways program, available through DHHS, connects people to community-based recovery resources across the state and can be a useful supplement to any clinical discharge plan. A facility that points patients toward these kinds of resources — rather than simply discharging them — is one that understands how recovery actually works.

10. Verify Your Insurance Coverage — Don’t Assume

This has become more complicated since 2024 and it’s worth explaining why.

In September 2024, federal agencies finalized updated rules under the Mental Health Parity and Addiction Equity Act (MHPAEA) that were intended to require insurers to cover substance use disorder treatment on genuinely equal footing with medical care — tighter prior authorization requirements, more transparent coverage documentation, stronger enforcement. Those rules took effect January 2025. In May 2025, however, the current administration announced it would not enforce the updated rules, leaving a gap between what the law intended and what insurers are currently required to demonstrate.

The practical result: don’t assume your insurance covers what you expect it to. Call your insurer directly, ask specifically what it covers for residential detox and inpatient rehab, ask whether prior authorization is required and what that process looks like, and get specifics in writing if possible.

Liberty’s insurance verification page walks through coverage before the admissions process begins. Their paying for rehab page outlines payment options clearly.

11. Red Flags Worth Noting

• Guaranteed outcomes. No reputable facility promises sobriety.
• No accreditation. Joint Commission or CARF accreditation should be easy to confirm. If a program can’t, ask why.
• Pressure to decide immediately. Urgency tactics have no place in healthcare.
• Vague answers about who delivers care. A legitimate program can tell you exactly who is providing therapy and what their credentials are.
• No MAT offered and no explanation why. In 2026, a blanket refusal of MAT warrants a real clinical rationale — not a policy position.
• No aftercare plan. Discharge into nothing is not treatment.
• Fixed program length. “28-day program” as a default is a scheduling structure, not a clinical one. Length of stay should be driven by individual need.

About Liberty Health Services

Liberty Health Services in Derry, New Hampshire is a Joint Commission accredited facility offering medically supervised detox and residential addiction treatment in a small, private setting.

With a 24-bed capacity, Liberty is intentionally not a high-volume program. Private rooms, chef-prepared meals, and on-site laundry provide a stable, comfortable environment. The clinical team — including licensed medical staff available 24/7 — builds individualized treatment plans around each patient’s substance history, mental health needs, and recovery goals. MAT is available for those for whom it’s clinically appropriate. Discharge planning and continuing care connections are part of every patient’s program.

If you’re ready to talk through your options or want to learn whether Liberty is a good fit, start with our admissions process or call (855) 689-5685.